CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
4.23%
1 Year Est. Return
-4.23%
AUM
$718M
AUM Growth
-$885M
(-55%)
Holding
35
Top Buys
| 1 | +$43.6M | |
| 2 | +$39.6M | |
| 3 | +$31.2M | |
| 4 |
Apellis Pharmaceuticals
APLS
|
+$14.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$5.5M |
Top Sells
| 1 | +$114M | |
| 2 | +$104M | |
| 3 | +$87.8M | |
| 4 |
CVS Health
CVS
|
+$82.8M |
| 5 |
PTC Therapeutics
PTCT
|
+$76.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$19.3B
| $91.2M | 8.56% |
1,000,000
-1,250,000
|
|
||
2
Baxter International
BAX
$9.63B
| $86.3M | 8.1% |
2,850,000
-2,900,000
|
|
||
3
Humana
HUM
$29.6B
| $73.3M | 6.89% |
300,000
-425,000
|
|
||
|
4
CVS Health
CVS
$102B
| $72.4M | 6.8% |
1,050,000
-1,200,000
|
|
||
5
Globus Medical
GMED
$12.2B
| $47.2M | 4.43% |
800,000
-450,000
|
|
||
6
Icon
ICLR
$14.1B
| $43.6M | 4.1% |
+300,000
|
|
||
7
Ascendis Pharma
ASND
$13B
| $43.1M | 4.05% |
250,000
-100,000
|
|
||
8
Merck
MRK
$260B
| $39.6M | 3.72% |
+500,000
|
|
||
9
Pfizer
PFE
$146B
| $36.4M | 3.41% |
1,500,000
-1,000,000
|
|
||
|
10
BioMarin Pharmaceuticals
BMRN
$10.7B
| $33M | 3.1% |
600,000
+100,000
|
|
||
11
UnitedHealth
UNH
$299B
| $31.2M | 2.93% |
+100,000
|
|
||
12
Viatris
VTRS
$12.3B
| $24.6M | 2.31% |
2,750,000
-4,750,000
|
|
||
13
Brookdale Senior Living
BKD
$2.65B
| $15M | 1.4% |
2,150,000
-4,100,000
|
|
||
|
ZIMV
14
DELISTED
ZimVie
ZIMV
| $15M | 1.4% |
1,600,000
-285,000
|
|
||
|
15
Apellis Pharmaceuticals
APLS
$2.69B
| $14.7M | 1.38% |
+850,000
|
|
||
16
Myriad Genetics
MYGN
$711M
| $10.6M | 1% |
2,000,000
-350,000
|
|
||
17
Evolent Health
EVH
$469M
| $9.57M | 0.9% |
850,000
-2,150,000
|
|
||
|
CON
18
Concentra Group Holdings
CON
$2.64B
| $8.23M | 0.77% |
400,000
-1,200,000
|
|
||
19
Inogen
INGN
$192M
| $6.85M | 0.64% |
975,000
|
|
||
20
Denali Therapeutics
DNLI
$2.86B
| $5.6M | 0.53% |
400,000
-850,000
|
|
||
21
Theravance Biopharma
TBPH
$1.03B
| $4.96M | 0.47% |
450,000
-550,000
|
|
||
22
AnaptysBio
ANAB
$1.15B
| $2.77M | 0.26% |
125,000
-625,000
|
|
||
23
OraSure Technologies
OSUR
$171M
| $2.7M | 0.25% |
900,000
|
|
||
24
Cigna
CI
$74.1B
| – | – |
-200,000
|
|
||
25
Genmab
GMAB
$19.9B
| – | – |
-50,000
|
|